Find Research Projects

Search results

• A Novel MRI Technique for the Diagnosis and Measurement of the progression of Amyotrophic Lateral Sclerosis

  Rowe, D.

  1/07/19 → 19/06/20

  Project: Research

• A novel neuro-cardiac self-regulation therapy to improve autonomic and neural function after SCI: Clinical trials and translation to implementation.

  Gopinath, B.

  Project: Research

• A novel optical stimulation method for Obstructive Sleep Apnoea Treatment

  McMullan, S., Bilston, L. & Burke , P.

  1/01/18 → 31/12/20

  Project: Other

• A novel social-cognitive program to improve real-world social interaction in Schizophrenia

  Marsh, P. & Langdon, R.

  21/01/10 → 20/01/11

  Project: Research

• ANSTO Scholarship - Quantifying the effects of surface and bulk proton transport in mantle minerals (Sarath Kumara)

  Clark, S. & Samaya Manthri Patabendi Gedara, S.

  23/09/16 → …

  Project: Research

• Answering longstanding plant ecology questions with new technology: the effects of changes in leaf proteins with age

  Westoby, M., Van Sluyter, S., Haynes, P., Gygi, S. P. & MQRES (International), M. (.

  1/01/14 → …

  Project: Research

• Antenna response of gamma-irradiated Queensland fruit flies

  Weldon, C., Collins, S. & Taylor, P.

  1/01/10 → 31/12/10

  Project: Research

• Antennas and Other Electromagnetic Components for Wireless-Enabled Complex Systems

  Esselle, K.

  12/02/11 → 29/07/11

  Project: Research

• Anthi

  Barkat, I. & Sivanathan, A.

  28/09/20 → 30/06/21

  Project: Research

• Antibiotic resistance: combining microscopy, microfluidics and genomics to target bacterial DNA repair pathways

  Robinson, A., Paulsen, I. & Jin, D.

  1/01/19 → 31/12/21

  Project: Other

• Antibiotic resistance and the ecological effects of selective decontamination of the digestive tract in Intensive Care Units

  Paulsen, I., Iredell, J., Partridge, S., Darling, A. & Seppelt, I.

  1/01/17 → …

  Project: Research

• Antimicrobial compounds from the model marsupial, the Tammar wallaby (Macropus eugenii )

  Ambatipudi, S.

  1/07/06 → 30/06/08

  Project: Research

• Ant inspired rules for self-assembly in swarm robotics and complex systems

  Reid, C.

  1/05/19 → 30/04/22

  Project: Research

• ACARP: Antiochia ad Cragum Archaeological Research Project

  Dodd, E.

  1/06/14 → …

  Project: Research

• AntiPort - Educating the Public on the risks and prevention of Mobile Number Porting Scams

  Trueck, S., Selby, J., Doche, C. & Boyd, M.

  1/02/19 → 31/12/20

  Project: Research

• Anywhere Working (Telework) and Telehealth Delivery: Productivity, Wellbeing and Service Quality

  Blount, Y., Markey, R. & Gloet, M.

  1/01/14 → 31/12/15

  Project: Research

• Aortic stiffness, Ventriculo-Arterial Coupling, Heart Mechanics and Coronary Supply: a Novel Sheep Model of Heart Failure with Preserved Ejected Fraction (HFPEF)

  Avolio, A.

  12/01/12 → 14/12/13

  Project: Research

• APA PhD scholarship

  Herke, M.

  1/02/02 → 30/06/05

  Project: Research

• APECS determination of Auger parameters of C and Si

  Thurgate, S. & van Rissen, G.

  23/04/07 → 25/04/07

  Project: Research

• A perception-based intervention for body size misperception

  Stephen, I.

  8/01/18 → …

  Project: Research

• A Personalized Social Network Based Location Search and Recommender System

  Yang, J., Orgun, M., Wang, Y., Air, M., Eichhorn, B. & Rej, T.

  1/05/13 → …

  Project: Research

• APEX AMI

  Brown, M.

  Project: Research

• A Pharmacological Targeting Approach Implementing Albumin as a Carrier of a Novel Chemotherapeutic

  Lovejoy, D., Kalinowski, D., Rahmanto, Y. & Ponka, P.

  1/01/13 → 31/12/15

  Project: Research

• ADG116-1003: A Phase 1, Open-Label, Dose Escalation Study of ADG116 in Patients with Advanced/Metastatic Solid Tumors

  Park, J., Chapman, N. & Sabanathan, D.

  14/09/20 → 27/08/25

  Project: Research

• Y-biologics: A Phase 1, Open-Label, Multicenter, Single Arm, Dose-Escalation/Dose-Expansion Study of YBL-006 in Patients with Advanced Solid Tumors

  Sabanathan, D., Park, J., Gurney, H., Chapman, N. & Rai, M.

  1/06/20 → 30/04/23

  Project: Research

• CS3002-101: A phase 1, open-label, multi-dose, dose escalation and expansion study to investigate the safety, tolerability, pharmacokinetics and anti-tumor activities of CS3002, a CDK4/6 inhibitor, in subjects with advance solid tumors

  Park, J., Sabanathan, D. & Chapman, N.

  30/10/20 → 24/09/25

  Project: Research

• SBT6050-1001: A Phase 1/1b, Open Label, Dose Escalation and Expansion Study of SBT6050 in Patients with Advanced Solid Tumors Expressing HER2

  Sabanathan, D., Park, J. & Chapman, N.

  2/09/20 → 27/08/25

  Project: Research

• LYT-100-2020-01: A Phase 1/1b Multiple Ascending Dose and Food Effect Study in Healthy Volunteers to Determine the Pharmacokinetics and Maximally Tolerated Dose of Deupirfenidone (LYT-100) Followed by Further Exploration in Patients with Breast Cancer-Related Upper Limb Secondary Lymphoedema

  Mackie, H., Koelmeyer, L. A., Chapman, N. & Rai, M.

  1/08/20 → 25/06/25

  Project: Research

• AB928CSP0002: A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants with Breast or Gynecologic Malignancies

  Sabanathan, D., Kefford, R., Cunningham, J. & Butala, R.

  6/12/18 → 5/12/23

  Project: Other

• A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma

  Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.

  16/05/19 → 15/05/24

  Project: Other

• A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma

  Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.

  16/05/19 → 15/05/24

  Project: Other

• A Phase 1B, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Ipatasertib in Combination with Rucaparib in patients with Advanced Breast, Ovarian, or Prostate Cancer

  Gurney, H., Chapman, N. & Butala, R.

  5/08/19 → 26/06/24

  Project: Other

• A Phase 1B/2 study to evaluate safety and anti-tumour activity of AVELUMAB in combination with POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) inhibitor TALAZOPARIB in patients with locally advance or metastatic solid tumours

  Sabanathan, D., Kefford, R., Butala, R. & Cunningham, J.

  19/07/18 → 21/06/23

  Project: Research

• XL184-021: A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors

  Park, J., Sabanathan, D., Gurney, H., Chapman, N. & Rai, M.

  28/08/20 → 30/04/25

  Project: Research

• C0541001: A PHASE 1 DOSE ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF PF 06804103 IN PATIENTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) POSITIVE AND NEGATIVEe SOLID TUMORS

  Sabanathan, D. & Chapman, N.

  21/09/20 → 31/05/25

  Project: Research

• SHR-A1811-1-101: A Phase 1 Multi-Country, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A1811 in HER2 Expressing or Mutated Advanced Malignant Solid Tumor Subjects

  Park, J. & Chapman, N.

  28/09/20 → 31/12/22

  Project: Research

• ZN-c5-002: A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with EstrogenReceptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

  Sabanathan, D., Park, J. & Chapman, N.

  15/10/20 → 14/10/25

  Project: Research

• Harbour Biomed 4003.1: A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 in Subjects with Advanced Solid Tumors

  Gurney, H., Chapman, N., Butala, R., Parshionikar, A. & Rajasekharan Nair, A.

  30/09/19 → 30/09/24

  Project: Other

• MISC_Covance Chiltern: A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting Programmed Death Ligand 1 (PD-L1) Protein in Patients with Advanced Solid Tumors

  Gurney, H., Butala, R. & Cunningham, J.

  16/07/18 → 15/07/23

  Project: Other

• A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer

  Gurney, H., Cunningham, J. & Butala, R.

  1/12/18 → 30/11/23

  Project: Other

• GALAXI: A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease

  Leong, R., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  30/09/19 → 7/05/24

  Project: Research

• VEGA: A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  Leong, R., Butala, R. & Chapman, N.

  24/09/19 → 11/07/24

  Project: Other

• A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies

  Gurney, H., Cunningham, J. & Butala, R.

  17/10/18 → 4/09/23

  Project: Other

• A Phase 3, multicenter, randomized, open-label, active-controlled study of DS-8201a, an anti-HER2-antibody drug conjugate, versus treatment of investigator’s choice for HER2-positive, unresectable and/or metastatic breast cancer subjects pretreated with prior standard of care HER2 therapies, including T-DM1

  Kefford, R., Butala, R. & Cunningham, J.

  12/03/19 → 25/11/23

  Project: Other

• A phase 3, placebo controlled, doubleblind,randomized, clinical study to determine efficacy, safety and tolerability of pulsed,inhaled nitric oxid (iNO) versus placebo in symptomatic subjects with

  Brown, M. & Butala, R.

  11/11/16 → 30/09/18

  Project: Research

• ADVANCE capacity: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension Who Recently Initiated Therapy

  Brown, M., Chapman, N., Rai, M. & Parshionikar, A.

  1/07/20 → 31/03/25

  Project: Research

• ADVANCE-outcomes: A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH: APD811-301

  Brown, M., Butala, R. & Chapman, N.

  17/10/19 → 30/06/22

  Project: Research

• LEAP-011: A Phase 3, Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Lenvatinib (E7080/MK-7902) Versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD-L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy Regardless of PD-L1 Expression: Protocol MK7902-011-00

  Zhang, A., Butala, R. & Chapman, N.

  13/09/19 → 6/06/24

  Project: Research

• A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.

  Zhang, A., Chapman, N. & Butala, R.

  6/08/19 → 18/06/24

  Project: Other

• KEYLYNK-010: A Phase 3, Randomized Open-label Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration resistant Prostate Cancer (mCRPC) Who are Unselected for Homologous Recombination Repair Defects and Have Failed Prior Treatment with One Next-generation Hormonal Agent (NHA) and Chemotherapy

  Gurney, H., Butala, R. & Chapman, N.

  9/09/19 → 30/05/24

  Project: Other